ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10059	Companies
205612	Keywords
135846	Articles
109010	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 04/29/2025 at 22:05, 10 months 22 days ago

Abivax annonce la fin du recrutement des patients dans le cadre de ses essais de phase 3 ABTECT dans le traitement de la rectocolite hémorragique (RCH) modérément à sévèrement active
Abivax annonce la fin du recrutement des patients pour ses essais de phase 3 ABTECT dans le traitement de la rectocolite hémorragique (RCH). Premiers résultats attendus T3 2025

Abivax Rectocolite Hémorragique Phase 3 ABTECT RCH
PRESS RELEASE

published on 04/29/2025 at 22:05, 10 months 22 days ago

Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
Abivax completes enrollment for Phase 3 ABTECT Trials in patients with active ulcerative colitis. Top-line results expected in Q3 2025, NDA submission planned for H2 2026

Abivax Ulcerative Colitis Phase 3 ABTECT Trials NDA Submission
BRIEF

published on 04/22/2025 at 22:10, 10 months 29 days ago

Abivax: Terms of the Annual General Meeting and outlook for 2025

Biotechnology Abivax Clinical Trials Investment General Meeting 2025
BRIEF

published on 04/22/2025 at 22:10, 10 months 29 days ago

Abivax : Modalités de l'Assemblée Générale Annuelle et perspectives 2025

Investissement Biotechnologie Abivax Essais Cliniques Assemblée Générale 2025
PRESS RELEASE

published on 04/22/2025 at 22:05, 10 months 29 days ago

Abivax annonce les modalités de son Assemblée Générale Annuelle alors que la Société se rapproche d’étapes clés créatrices de valeur en 2025
Abivax annonce les modalités de son Assemblée Générale Annuelle pour le 6 juin 2025 à Paris, alors que la Société se rapproche d'étapes clés en 2025

Biotechnologie Abivax Assemblée Générale Annuelle Phase 3 Mécanismes De Régulation
PRESS RELEASE

published on 04/22/2025 at 22:05, 10 months 29 days ago

Abivax annonce les modalités de son Assemblée Générale Annuelle alors que la Société se rapproche d’étapes clés créatrices de valeur en 2025
Abivax annonce les modalités de son Assemblée Générale Annuelle et se rapproche d'étapes clés créatrices de valeur en 2025. Essais cliniques ABTECT de phase 3 en progression

Abivax Étapes Clés Assemblée Générale Annuelle Phase 3 ABTECT
BRIEF

published on 04/22/2025 at 22:05, 10 months 29 days ago

Abivax accueille le Dr Dominik Höchli au sein de son Conseil d’administration

Abivax Conseil D'administration Phase 3 Immunologie Dominik Höchli
BRIEF

published on 04/22/2025 at 22:05, 10 months 29 days ago

Abivax welcomes Dr. Dominik Höchli to its Board of Directors

Board Of Directors Abivax Phase 3 Immunology Dominik Höchli
PRESS RELEASE

published on 04/22/2025 at 22:05, 10 months 29 days ago

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Abivax announces details of Annual General Meeting on June 6, 2025, in Paris as it progresses towards key 2025 milestones, including Phase 3 ABTECT trials

Annual General Meeting Abivax Clinical-stage Biotechnology Phase 3 ABTECT Trials 2025 Milestones
PRESS RELEASE

published on 04/22/2025 at 22:00, 10 months 29 days ago

Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Abivax nomme le Dr Dominik Höchli au Conseil d’administration pour renforcer son expertise en immunologie avant la publication des données clés de l’étude de phase 3 dans la rectocolite hémorragique en 2025

Abivax Conseil D'administration Rectocolite Hémorragique Immunologie Dr Dominik Höchli

Accesswire

Published on 03/20/2026 at 23:00, 1 day 22 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 2 days ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 2 days ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 2 days 8 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 9 hours ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

EQS Group

Published on 03/22/2026 at 18:22, 3 hours 15 minutes ago

Test news - please ignore EN
Published on 03/22/2026 at 12:23, 9 hours 14 minutes ago

Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 22 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 2 days ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion

Les Echos

Published on 03/20/2026 at 19:00, 2 days 2 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 2 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 3 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 3 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 2 days 3 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE